K83.1
Conditions
Interventions
Group 1: Patienten mit Cholestase durch ein perihiläres Gallengangskarzinom und geplant palliativer Therapie.
Sponsors
Asklepios Klinik Barmbek
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Hilar Cholangiocarcinoma Bismuth Corlette Stage II-IV Cholestasis Endoscopic therapy Complete clinical and laboratory documentation in the electronic patient documentation system
Exclusion criteria
Exclusion criteria: Non malignant Cholestasis Cholestasis due to tumors other than Hilar Cholangiocarcinoma Missing laboratory or clinical documentation Endosonographic therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Success (Reduction of Total Serum Bilirubin) | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of Interventions Type of Interventions Adverse Events Predictive factors for Clinical Success | — |
Countries
Germany
Contacts
Public ContactThomas von Hahn
Asklepios Klinik Barmbek
Outcome results
None listed